B
rilliant blue G (BBG) selectively stains the internal limiting membrane (ILM), improving visualization during ILM peeling. 1 Despite controversy about the safety profile of the dye, BBG has been widely used intraoperatively in many countries. 1 Accidental delivery of dyes into the subretinal space is a well-known complication associated with macular surgical procedures. [2] [3] [4] [5] In this report, we describe the outcomes of retinal function and structure during 2 years in a patient after epiretinal membrane (ERM) and ILM peeling with accidental migration of BBG into the subretinal space at the macular area.
Report of a Case
A man in his 60s presented with decreased visual acuity and progressive metamorphopsia for 6 months in his right eye. The patient had a history of glaucoma and had been monitored in our clinic for the past 5 years with well-controlled intraocular pressure and stable visual field defects.
Examination demonstrated a best-corrected visual acuity (BCVA) of 20/70 OD and 20/20 OS. Intraocular pressure was 13 mm Hg and 12 mm Hg, respectively. Slitlamp examination demonstrated mild nuclear sclerosis in each eye. Dilated ophthalmoscopic examination demonstrated thinning of the neuroretinal rim in each eye and an ERM with vascular tortuosity in the right eye. Optical coherence tomography (Heidelberg retinal angiography; Heidelberg Engineering) of the right eye was notable for an ERM and a central subfield macular thickness (CSMT) of 596 μm ( Figure 1 ). Multifocal electroretinography (mfERG) (Espion E2; Diagnosys LLC) of the right eye revealed amplitude and implicit times within the reference range ( Figure 2 ).
Surgical Procedure
Phacoemulsifications with posterior chamber intraocular lens (MA60AC +22.5 diopters; Alcon Inc) placement, followed by 23-gauge pars plana vitrectomy (Accurus system; Alcon/ Grieshaber), were performed on the right eye. Three nonvalved trocars (Alcon Inc) were placed, and triamcinolone acetonide, 0.4 mg, in 0.1 mL (Ophthalmos) was used to stain the IMPORTANCE This case report describes a man who developed retinal changes in his right eye associated with brilliant blue G migration into the subretinal space during 2 years of follow-up.
OBSERVATION The patient's best-corrected visual acuity in the right eye was 20/70 before surgery, and it improved to 20/25 at 1 year after surgery. Fluorescein angiography showed staining during the late phase in the central macula at all follow-up visits after surgery. Multifocal electroretinography demonstrated normal amplitude and implicit times before surgery but decreased amplitudes and increased implicit times in at least 5 contiguous hexagons after surgery on all 3 examinations performed during the 2-year follow-up period. These functional changes were not topographically correlated with the area of fluorescein staining or with the internal limiting membrane peeled area, but were matched to the area where brilliant blue G accidentally entered the subretinal space. Microperimetry demonstrated reduced retinal threshold sensitivity, particularly in areas with decreased multifocal electroretinography amplitude.
CONCLUSIONS AND RELEVANCE Despite the visual acuity improvement observed in this case, multifocal electroretinography and microperimetry indicate that subretinal brilliant blue G might cause focal macular damage with a decrease of macular function suggestive of a toxic effect.
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vitreous and facilitate posterior hyaloid detachment. The ERM was removed with a macular forceps.
With the infusion line closed, a solution of BBG, 0.05% (Ophthalmos), 280 mOsm (0.3 mL in a 5-mL syringe), was injected through a 23-gauge soft-tip silicone cannula into the vitreous cavity directed toward to the optic nerve. An accidental BBG flush was noted during the infusion, presumably due to excessive pressure.
After the BBG was removed from the vitreous cavity, subretinal BBG was visualized in the macula despite the absence of retinal breaks ( Figure 3A and Video). The ILM was peeled, and no internal drainage of the subretinal BBG was performed. Fluid-air exchange was conducted (approximately 25 mm Hg) just before the operation was completed.
Postoperative Evaluations
A blue area corresponding to the submacular BBG was visualized on the first postoperative day but was no longer visible 7 days later. The patient's BCVA, metamorphopsia, and CSMT improved progressively. At 3 months postoperatively, his BCVA was 20/50 and optical coherence tomography demonstrated some cystoid macular edema with a CSMT of 431 μm. At 5 months postoperatively, the BCVA had decreased to 20/80 and optical coherence tomography demonstrated increased cystoid macular edema with a CSMT of 533 μm. Therefore, an intravitreal injection of triamcinolone acetonide, 1 mg, was administered and was associated with an improvement in BCVA (20/25 at 1 year) and CSMT, which remained stable throughout 2 years of follow-up (Figure 1) .
Fluorescein angiography was performed at 1, 3, 6, 12, and 24 months after surgery. Figure 3C shows postoperative fluorescein angiography that revealed no leakage around the optic nerve area (no sign of edema) and macula staining, probably due to a window defect in consequence of retinal pigment epithelium atrophy. The area of staining was smaller than the area where the ERM had been located, smaller than the area of ILM peeling, and smaller than the area where the subretinal BBG had been visualized ( Figure 3D ).
Multifocal electroretinography demonstrated amplitude and implicit times within the reference range before surgery, but an amplitude reduction was observed postoperatively in the retinal area between the fovea and the optic disc up to the 12-month postoperative visit. In addition, a predominantly central mfERG amplitude reduction was observed 24 months postoperatively. There was a region in which the mfERG responses showed reduced amplitude and increased implicit time (>20%) in at least 5 contiguous hexagons compared with preoperative values at postoperative month 1; these abnormal mfERG responses remained stable from postoperative month 1 through postoperative month 12 (Figure 2 ). At postoperative month 24, an overall improvement in mfERG responses was observed, probably owing to reorganization of the inner retina, although the central amplitude density (P1 amplitude in nanovolts per degree 2 divided by the correspondent stimulus hexagon area) remained reduced.
Discussion
It is well established that removal of the ILM during ERM surgery helps to decrease ERM recurrence 6 and that ERM and ILM can be peeled more easily if stained with dyes such as triamcinolone acetonide, trypan blue, or BBG. 7 This report describes accidental subretinal BBG entry, presumably through an unobserved retinal hole induced by the dye jet stream 2 that we believe was at the temporal edge of the optic disc. Postoperatively, our patient developed cystoid macular edema, which was treated with a single intravitreal injection of triamcinolone acetonide, with subsequent improvement in his BCVA and CMST. Nevertheless, we found functional and structural retinal abnormalities during follow-up, including staining on fluorescein angiography and reduced amplitudes and increased implicit times in the macula on mfERG. There are previous reports 8, 9 of changes shown on fluorescein angiography and optical coherence tomography (window defects and outer retina damage) in the areas of the retina exposed to subretinal BBG, but there is no definitive evidence that these findings were due to the dye. It is also known that mfERG abnormalities may be present in eyes with ERM and that a further amplitude reduction may be observed in the peeled areas after surgery, even without the use of intraoperative dyes. 10 For instance, Tari et al We found focal mfERG changes (decreased amplitudes and increased implicit times) after ILM peeling surgery in all 4 mfERG examinations performed during the 2-year postoperative period. These changes were not topographically correlated with the area of fluorescein staining or to the peeled area, but they were correlated with the area where BBG accidentally entered the subretinal space (Figure 3) . Unfortunately, microperimetry results were available only for the 24-month postoperative visit, but the results indicated good topographic correspondence between areas of mfERG amplitude reduction and retinal threshold sensitivity.
The visual acuity improvement to 20/25 provides evidence against a toxic process involving the fovea, which could be explained if the dye did not reach the foveal area, which apparently is what happened in our patient.
Conclusions
Accidental subretinal migration of BBG, 0.05%, may cause cystoid macular edema and a persistent decrease of retinal function owing to a direct mechanical and/or toxic effect on retinal tissue. Studies are warranted to confirm such observations, and the development of safer intraoperative delivery method of dyes during chromovitrectomy is advisable.
